Trials / Completed
CompletedNCT00406289
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor
Phase I Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) With Patients With Head and Neck Tumor
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the feasibility of higher and prolonged dose escalation concentrated in the intra-tumoral regions which are FDG-avid after two weeks of radiotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 18F-FDG-PET radiotherapy |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2009-08-01
- Completion
- 2010-02-01
- First posted
- 2006-12-04
- Last updated
- 2010-09-06
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00406289. Inclusion in this directory is not an endorsement.